Cryptococcosis in AIDS

被引:34
作者
Imwidthaya, P [1 ]
Poungvarin, N
机构
[1] Mahidol Univ, Dept Microbiol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand
[2] Mahidol Univ, Dept Med, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand
关键词
Cryptococcus neoformans; AIDS; polymerase chain reaction fingerprinting; antifungal agents;
D O I
10.1136/pmj.76.892.85
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A total of 87 patients (17 female, 70 male) were admitted to Siriraj Hospital, Mahidol University, Bangkok, Thailand, from January 1996 to December 1997, with a diagnosis of cryptococcal meningitis and underlying AIDS. The age range was 14-70 years, mean 32.1. Six females (35%) and thirty-one males (44%) died, while the others were discharged home after clinical improvement. The mean duration of admission of those who died was 14.5 days, which was shorter than that of the patients who survived (25.7 days). Cerebral cryptococcosis was diagnosed using culture (100%), India ink preparation (91%), latex agglutination test (100%), and polymerase chain reaction (86%). Polymerase chain reaction fingerprinting of Cryptococcus neoformans revealed 99% serotype A and 1% serotype B. The mean minimum inhibitory concentrations of amphotericin B, flucytosine, fluconazole and itraconazole against 87 isolates of C neoformans were 0.55 mu g/ml (0.25-1, SD = 0.22), 9.5 mu g/ml (2-20, SD = 4.91), 6.9 mu g/ml (1-16, SD = 4.42) and 0.36 mu g/ml (0.125-1.0, SD = 0.23), respectively. These findings showed that the cryptococcal infections were sensitive to these antifungal agents.
引用
收藏
页码:85 / 88
页数:4
相关论文
共 21 条
[1]   2-SITE COMPARISON OF BROTH MICRODILUTION AND SEMISOLID AGAR DILUTION METHODS FOR SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS IN 3 MEDIA [J].
ANAISSIE, E ;
SHAWAR, R ;
PAETZNICK, V ;
ENSIGN, LG ;
WITTE, Z ;
LAROCCO, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (05) :1370-1372
[2]   COMPARATIVE-STUDY OF BROTH MACRODILUTION AND MICRODILUTION TECHNIQUES FOR IN-VITRO ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS BY USING THE NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS PROPOSED STANDARD [J].
BARCHIESI, F ;
COLOMBO, AL ;
MCGOUGH, DA ;
RINALDI, MG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) :2494-2500
[3]  
Bowman Barbara H., 1993, P423
[4]   IN-VITRO DETERMINATION OF OPTIMAL ANTIFUNGAL COMBINATIONS AGAINST CRYPTOCOCCUS-NEOFORMANS AND CANDIDA-ALBICANS [J].
GHANNOUM, MA ;
FU, Y ;
IBRAHIM, AS ;
MORTARA, LA ;
SHAFIQ, MC ;
EDWARDS, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2459-2465
[5]  
IMWIDTHAYA P, 1991, Journal of the Medical Association of Thailand, V74, P454
[6]   CLINICAL AND ENVIRONMENTAL ISOLATES OF CRYPTOCOCCUS-NEOFORMANS IN BANGKOK (THAILAND) [J].
IMWIDTHAYA, P ;
DITHAPRASOP, P ;
EGTASAENG, C .
MYCOPATHOLOGIA, 1989, 108 (01) :65-67
[7]  
Imwidthaya P, 1997, SIRIRAJ HOSP GAZ, V49, P1145
[8]   EPIDEMIOLOGIC DIFFERENCES BETWEEN THE 2 VARIETIES OF CRYPTOCOCCUS-NEOFORMANS [J].
KWONCHUNG, KJ ;
BENNETT, JE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1984, 120 (01) :123-130
[9]  
LEELARASSAMI A, 1982, B INF DIS BR THAI, V5, P52
[10]   HYBRIDIZATION PROBES FOR CONVENTIONAL DNA-FINGERPRINTING USED AS SINGLE PRIMERS IN THE POLYMERASE CHAIN-REACTION TO DISTINGUISH STRAINS OF CRYPTOCOCCUS-NEOFORMANS [J].
MEYER, W ;
MITCHELL, TG ;
FREEDMAN, EZ ;
VILGALYS, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (09) :2274-2280